ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1430

Research Priorities for Addressing Mental Health Needs of Pediatric Patients with Rheumatologic Disease

Tamar Rubinstein1, Lindsay Waqar2, Jennifer Woo3, Ekemini Ogbu4, W. Blaine Lapin5, Lawrence Ng6, Erin Treemarcki7 and Andrea M. Knight8, 1Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3University of California Los Angeles, Los Angeles, CA, 4Pediatrics, Emory University, Atlanta, GA, 5Baylor College of Medicine, Houston, TX, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Hospital for Special Surgery Weill Cornell Medical College, New York, NY, 8Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: mental health and pediatric rheumatology, Research

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Mental health problems are prevalent in pediatric rheumatology patients. Gaps in knowledge exist regarding the detection, effective treatment, and the impact of mental illness on patients with rheumatologic disease. To address these gaps and direct research efforts to improve mental health for children and adolescents with rheumatologic diseases, the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Mental Health Workgroup developed and prioritized an agenda of research topics.

Methods:  A systematic review of the literature on mental health in pediatric rheumatology was completed and published. From the review, 5 major research domains in further need of study were identified: (A) mental health burden and relationship to pediatric rheumatologic disease, (B) impact of mental health disorders on outcomes, (C) mental health awareness and education, (D) mental health screening, and (E) mental health treatment. Research topics within these areas were developed and presented at the CARRA Mental Health Workgroup Annual Meeting in April 2018, where they were discussed and refined. An online survey was created to prioritize the 33 refined topics.The survey was emailed to 132 people who expressed interest in the workgroup, including pediatric rheumatologists, patients/parents, research coordinators, psychologists, social workers, and members of industry. Participants were asked to: i) grade each research topic on a 5-point Likert scale on how important, feasible, and actionable they were, and ii) provide an overall ranking of the research topics within each research area.

Results: Fifty-six (42%) responded to the survey, and 45 of the respondents completed the survey (80%). Topics related to the impact of mental health on clinical outcomes were rated most important, and those related to mental health screening were rated most feasible and actionable (Table 1). Overall rankings revealed additional topics of high priority within each research domain (Figure 1).

Conclusion: Addressing gaps in knowledge about how mental health affects youth with rheumatologic disease and how best to address mental health for these patients is an important step in improving care. We have identified high priority research topics regarding mental health of pediatric rheumatology patients in need of further investigation, that are feasible to study and believed to lead to actionable results in patient care.

 

Table 1. Highest Scored Research Topics for Mental Health Research in Pediatric Rheumatology by Importance, Feasibility, and Actionability:

 

Research Topic:

Mean Score (±SD)

(1=Low, 5=High):

Most Important:

 

(B1) Investigate the impact of mental health on clinical outcomes, such as disease activity.

4.7 (±0.5)

(A1) Determine the prevalence and incidence of mental health disorders in pediatric patients with rheumatologic disease, as well as socio-demographic and disease-specific risk factors.

4.7 (±0.5)

(B2) Investigate the impact of mental health on long-term clinical outcomes, such as disease damage and mortality.

4.6 (±0.6)

Most Feasible:

 

(D4) Determine barriers and facilitators to mental health screening for pediatric patients with rheumatologic disease.

4.2 (±0.9)

(D2) Determine the accuracy of mental health screening tools for identifying mental health conditions in specific pediatric rheumatology disease populations (i.e. validation of tools for disease-specific diagnostic cut-points).

4.1 (±0.7)

(A1) Determine the prevalence and incidence of mental health disorders in pediatric patients with rheumatologic disease, as well as socio-demographic and disease-specific risk factors.

4.1 (±0.8)

Most Actionable:

 

(D1) Determine which mental health conditions are most important to screen for in pediatric patients with rheumatologic disease.

4 (±0.8)

(D2) Determine the accuracy of mental health screening tools for identifying mental health conditions in specific pediatric rheumatology disease populations (i.e. validation of tools for disease-specific diagnostic cut-points).

3.9 (±0.7)

(D5) Determine acceptability of mental health screening in pediatric rheumatology clinics for patients, caregivers, and clinicians, and identify strategies to improve acceptability.

3.9 (±0.8)

Means and standard deviations presented of the highest ranking research topics from 33 developed research topics addressing mental health in pediatric rheumatology around importance (relevance of the topic to advancing clinical care and research, considering existing knowledge), feasibility (ease with which research related to the topic can be conducted and completed), and actionability (ability to apply the results of research on the topic towards advancing clinical care and pediatric rheumatology research). Likert scale responses were 1 = Low, 2 = Somewhat Low, 3 = Neutral, 4 = Somewhat High, 5 = High.

 


Disclosure: T. Rubinstein, None; L. Waqar, None; J. Woo, None; E. Ogbu, None; W. B. Lapin, None; L. Ng, None; E. Treemarcki, None; A. M. Knight, None.

To cite this abstract in AMA style:

Rubinstein T, Waqar L, Woo J, Ogbu E, Lapin WB, Ng L, Treemarcki E, Knight AM. Research Priorities for Addressing Mental Health Needs of Pediatric Patients with Rheumatologic Disease [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/research-priorities-for-addressing-mental-health-needs-of-pediatric-patients-with-rheumatologic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/research-priorities-for-addressing-mental-health-needs-of-pediatric-patients-with-rheumatologic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology